Effects of SGLT-2 inhibitors on clinical and biological hyperandrogenism and menstruation irregularities in patients with polycystic ovary syndrome: A systematic review of randomized trials

Effects of SGLT-2 inhibitors on clinical and biological hyperandrogenism and menstruation irregularities in patients with polycystic ovary syndrome: A systematic review of randomized trials

Introduction: Polycystic ovary syndrome is a common chronic condition characterized by insulin resistance and hyperandrogenism, leading to significant health risks and impaired quality of life. Sodium-glucose transporter type 2 inhibitors have shown promise in improving the metabolic profile of wome...

Full description

Saved in:

Bibliographic Details
Main Authors:	Houcem Elomma Mrabet, Houda Ben Salem, Taieb Ach, Asma Ben Abdelkarim, Wafa Alaya
Format:	Article
Language:	English
Published:	SAGE Publishing 2024-12-01
Series:	SAGE Open Medicine
Online Access:	https://doi.org/10.1177/20503121241308997
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Population and Diagnostic Characteristics of Polycystic Ovary Syndrome and Hyperandrogenism
by: Crystal Clark Douglas, et al.
Published: (2024-04-01)

Impact of non-severe infections on cortisol and thyroid stimulating hormone baseline levels in hospitalized patients: A monocentric cross-sectional study
by: Mrabet Houcem Elomma, et al.
Published: (2024-01-01)

Subclinical Hypothyroidism in Polycystic Ovary Syndrome: Prevalence and Impact on Metabolic and Cardiovascular risk
by: Taieb Ach, et al.
Published: (2025-06-01)

Impact of Polycystic Ovary Syndrome Hyperandrogenic Phenotypes A and Non-Hyperandrogenic D on Pregnancy Outcomes After in vitro Fertilization (IVF)/Intracytoplasmic Sperm Injection (ICSI)
by: Khamaiseh K, et al.
Published: (2025-03-01)

The effect of correction of serum level of vitamin D on hyperandrogenism in women with polycystic ovary syndrome and hypovitaminosis D
by: A. M. Maysara, et al.
Published: (2020-04-01)

Optimal Fasting Insulin Cutoff Value to Predict Clinical and/or Biochemical Hyperandrogenism in Korean Women with Polycystic Ovary Syndrome
by: Seula Lee, et al.
Published: (2023-11-01)

Hyperandrogen-induced imbalance of FOXO4-AR regulatory loop contributes to ovulatory disorders in polycystic ovary syndrome
by: Ruiqiong Zhou, et al.
Published: (2025-06-01)

Thiamine Deficiency Neuropathy in a Patient with Malnutrition due to Melancholic Depression
by: Rihene Melki, et al.
Published: (2024-01-01)

Effects of non-pharmacological interventions on biochemical hyperandrogenism in women with polycystic ovary syndrome: a systematic review and network meta-analysis
by: Qi Jin, et al.
Published: (2025-01-01)

Hypomethylation‐Triggered SERPINE1 (Serpin Family E Member 1) Exacerbates Polycystic Ovary Syndrome with Hyperandrogenism Induced by Circadian Disruption
by: Xueying Geng, et al.
Published: (2025-07-01)

IRREGULAR MENSTRUATION THERAPY WITH ACUPUNCTURE, POMEGRANATE PEEL AND GINGER HERBS
by: Sinta Diyah Dimyati, et al.
Published: (2020-07-01)

Menstruation and masculinity: Exploring the relationship between boys and menstruation
by: Anusree Jayamohan, et al.
Published: (2024-10-01)

Spironolactone and metformin combination therapy as a potential non-hormonal treatment for management of hyperandrogenic symptoms of polycystic ovarian syndrome
by: Irene Karderinis, et al.
Published: (2025-07-01)

Immunophenotypic Profiles in Polycystic Ovary Syndrome
by: Cong Hu, et al.
Published: (2020-01-01)

Diagnosis and treatment of polycystic ovary syndrome
by: Ronelsys Martínez Martínez, et al.
Published: (2023-11-01)

From the history of polycystic ovary syndrome
by: D. A. Kiryushkina
Published: (2019-09-01)

Polycystic Ovary Syndrome - treatment update
by: Marta Szymura, et al.
Published: (2025-07-01)

Review on: Women with Polycystic Ovary Syndrome
by: Neelam Gusain, et al.
Published: (2025-05-01)

The prevalence of polycystic ovaries in infertility by laparoscopy ‎
by: Tahereh Ziaie, et al.
Published: (2013-09-01)

Valproate Induced Obesity and Polycystic Ovaries
by: J Gordon Millichap
Published: (1996-06-01)

Frequency of Polycystic Ovary Syndrome and “Being at Risk for Polycystic Ovary Syndrome” in Obese Adolescent Girls in Light of Current Definitions
by: Özlem Yüksel, et al.
Published: (2025-09-01)

Violation of the Hormonal Spectrum in Polycystic Ovaries in Combination with Insulin Resistance. What is the Trigger: Insulin Resistance or Polycystic Ovary Disease?
by: Lomteva S V, et al.
Published: (2022-10-01)

Diagnostic Dilemma in Two Cases of Hyperandrogenism
by: Ibrahim Alali, et al.
Published: (2018-01-01)

Hyperandrogenism as a side effect of anticonvulsants
by: E. V. Tsallagova, et al.
Published: (2018-08-01)

The influence of obesity on hyperandrogenism and infertility in the female
by: M.T. van der Merwe
Published: (2003-04-01)

Postmenopausal Hyperandrogenism due to Ovarian Hyperthecosis
by: Laryssa Santos Metzker, et al.
Published: (2023-01-01)

Polycystic ovary syndrome: pathophysiology and therapeutic opportunities
by: Jiawen Dong, et al.
Published: (2023-11-01)

Body Fat Distribution in Thai Reproductive-Aged Polycystic Ovary Syndrome Women Compared with Non-Polycystic Ovary Syndrome Women
by: Thanyarat Wongwananuruk, et al.
Published: (2024-02-01)

Distribution of polycystic ovary syndrome (PCOS) phenotypes in Iranian women: a cross-sectional study
by: Asma Kheirollahi, et al.
Published: (2025-05-01)

The association of rs7041 polymorphism with infertility and recurrent pregnancy loss in Iranian women with polycystic ovary syndrome
by: Hediyeh Hamidi, et al.
Published: (2025-05-01)

Management of “hyperandrogenism” confounded by dermatology biotin prescriptions
by: Sumal S. Sundar, et al.
Published: (2024-12-01)

Multisystem Health Consequences of Prenatal Hyperandrogenism in Offspring
by: Dong Liu, et al.
Published: (2024-10-01)

Concurrent autoimmune and endocrine dysregulation in polycystic ovary syndrome
by: Halah Amer Abduljabbar, et al.
Published: (2025-07-01)

Immunological aspects of polycystic ovary syndrome: A review
by: Yulia A. Kandrashlina, et al.
Published: (2025-01-01)

Polycystic Ovary Syndrome (PCOS): Symptoms, Causes, and Treatment
by: Hai Bai, et al.
Published: (2024-05-01)

Modern aspects of management of patients with polycystic ovary syndrome
by: N. V. Avramenko, et al.
Published: (2020-12-01)

Polymorphisms of cytochrome genes in women with polycystic ovary syndrome
by: A. Yu. Beglova, et al.
Published: (2019-09-01)

Serum afamin levels in women with polycystic ovary syndrome
by: Md. Jaminur Rashid, et al.
Published: (2025-04-01)

Polycystic Ovary Syndrome – A Clinical and Psychosocial Perspective
by: Paulina Strzałkowska, et al.
Published: (2025-07-01)

Polycystic ovary syndrome: Criteria, phenotypes, race and ethnicity
by: Tsuyoshi Baba
Published: (2025-01-01)